WEISS PAUL M 4
4 · Tamir Biotechnology, Inc. · Filed Jul 25, 2012
Insider Transaction Report
Form 4
WEISS PAUL M
Director
Transactions
- Award
Common Stock (Right to Buy)
2012-07-23+375,000→ 375,000 totalExercise: $0.04From: 2012-12-31Exp: 2017-12-31→ Common Stock (375,000 underlying)
Footnotes (1)
- [F1]Issued under the Company's 2004 Stock Incentive Plan and qualified under Rule 16b-3(d).